|
|
Volumn 41, Issue 5, 2002, Pages 495-496
|
|
Quetiapine-associated hyperglycemia and hypertriglyceridemia [3]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ATYPICAL ANTIPSYCHOTIC AGENT;
CHOLESTEROL;
CLOZAPINE;
GLUCOSE;
METFORMIN;
NEUROTRANSMITTER;
OLANZAPINE;
PAROXETINE;
PSYCHOTROPIC AGENT;
QUETIAPINE;
RISPERIDONE;
TRIACYLGLYCEROL;
VALPROATE SEMISODIUM;
VALPROIC ACID;
DIBENZOTHIAZEPINE DERIVATIVE;
NEUROLEPTIC AGENT;
ADOLESCENT;
BIPOLAR DISORDER;
CASE REPORT;
CHOLESTEROL BLOOD LEVEL;
CLINICAL FEATURE;
CONDUCT DISORDER;
DIABETIC DIET;
DRUG DOSE REGIMEN;
DRUG UTILIZATION;
DRUG WITHDRAWAL;
FEMALE;
GLUCOSE BLOOD LEVEL;
GLUCOSE METABOLISM;
HUMAN;
HYPERGLYCEMIA;
HYPERTRIGLYCERIDEMIA;
LETTER;
MENTAL DEFICIENCY;
NON INSULIN DEPENDENT DIABETES MELLITUS;
OUTCOMES RESEARCH;
PRIORITY JOURNAL;
SIDE EFFECT;
TRIACYLGLYCEROL BLOOD LEVEL;
WEIGHT GAIN;
CHEMICALLY INDUCED DISORDER;
DRUG COMBINATION;
RISK FACTOR;
ADOLESCENT;
ANTIPSYCHOTIC AGENTS;
BIPOLAR DISORDER;
DIABETES MELLITUS, TYPE 2;
DIBENZOTHIAZEPINES;
DRUG THERAPY, COMBINATION;
FEMALE;
HUMANS;
HYPERGLYCEMIA;
HYPERTRIGLYCERIDEMIA;
RISK FACTORS;
|
|
EID: 0036582325
PISSN: 08908567
EISSN: None
Source Type: Journal
DOI: 10.1097/00004583-200205000-00004 Document Type: Letter |
|
Times cited : (40)
|
|
References (5)
|
